Posts with tag: software development
Emcore Corp. reports a Q1 loss of $5.5 million, or 61 cents per share. Adjusted earnings were 5 cents per share on revenue of $19.3 million.
Published on: February 13, 2025, 10:08 PM UTC
Despite pressure from the Trump administration, incoming Secretary of Education Linda McMahon commits to preserving the Public Service Loan Forgiveness program.
Published on: February 13, 2025, 08:01 PM UTC
Nvidia recovers as smart money nibbles, Palantir attracts retail investors despite insider selling
Published on: February 13, 2025, 07:03 PM UTC
Elon Musk threatens to withdraw his $97.4 billion bid for OpenAI if the non-profit transforms into a for-profit enterprise. Altman, CEO of OpenAI, breached his responsibility by turning down the bid from a Musk-led investor group. The case revolves around Musk's initial $45 million donation, contingent on OpenAI remaining a non-profit.
Published on: February 13, 2025, 07:03 PM UTC
Gold climbs towards another record as the dollar falls, with traders assessing America's push to end the Ukraine war and President Donald Trump's moves on trade.
Published on: February 13, 2025, 05:00 PM UTC
UK's per capita GDP falls for second quarter, prompting concerns about productivity and economic performance under Chancellor Rachel Reeves' policies.
Published on: February 13, 2025, 02:00 PM UTC
Crocs Inc. (CROX) reports fourth-quarter earnings of $368.9 million, exceeding Wall Street expectations. Earnings per share were $6.36, adjusted to $2.52. Revenue reached $989.8 million, also topping forecasts.
Published on: February 13, 2025, 01:07 PM UTC
CVS stock surges 15% on conservative 2025 outlook, earnings beat; CEO defends PBM unit
Published on: February 13, 2025, 01:03 PM UTC
PBF Energy reports a third straight quarterly loss as refining margins decline. The refiner's Q4 loss of $289.3 million is attributed to lower margins and reduced throughput.
Published on: February 13, 2025, 12:00 PM UTC
Trump administration cuts to NIH "indirect costs" funding cause concern in the drug research world, with potential trickle-down effects on mass layoffs, project cancellations, and reductions in biomedical research. The move, aimed at saving the government $4 billion, has sparked a lawsuit by 22 states and a temporary halt by a federal judge.
Published on: February 13, 2025, 10:01 AM UTC